UA

Uttam Agrawal

Active Director Designated Partner DIN 10802216
DIN 10802216 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Uttam Agrawal

Data last updated:

Uttam Agrawal is a Designated Partner at Sanskaar Sanjeevani Pharmaceuticals Llp (since 2024). The company operates in Pharma.

DIN 10802216
Primary Designation Designated Partner
Industry Pharma
First Appointment 08 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Oct 20242024Active

Board colleagues of Uttam Agrawal

NameDINCompanyDesignation
Agam Agrawal10802215Sanskaar Sanjeevani Pharmaceuticals LlpDesignated Partner
Amit08150543Sanskaar Sanjeevani Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Sanskaar Sanjeevani Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Uttam Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Uttam Agrawal

Uttam Agrawal currently holds 1 directorship: Sanskaar Sanjeevani Pharmaceuticals Llp (Designated Partner, since 08 Oct 2024).

Uttam Agrawal was first appointed on 08 Oct 2024 as Designated Partner at Sanskaar Sanjeevani Pharmaceuticals Llp.

The current boards of Uttam Agrawal's companies include Agam Agrawal (Sanskaar Sanjeevani Pharmaceuticals Llp), Amit (Sanskaar Sanjeevani Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available